Advancing Pharmacy Practice and Patient CareSingapore Pharmacy Council Annual Report 2017
The Singapore Pharmacy Council (SPC) serves as the regulatory authority for the pharmacy profession in Singapore. Established under the Pharmacist Registration Act, the Council is responsible for maintaining professional standards, ensuring pharmacists' competency, and safeguarding public interest in pharmaceutical services. The 2017 Annual Report highlights the Council's significant progress in various regulatory and developmental functions throughout the year.
The report reflects on strategic initiatives undertaken to enhance pharmacy standards, challenges faced, and the vision for the future of pharmacy practice in Singapore. Under the guidance of the Ministry of Health, the SPC continues to evolve in tandem with Singapore's healthcare transformation, addressing changing patient needs, emerging trends in pharmacy practice, and international best practices.
2017 was a milestone year for the Singapore Pharmacy Council. The following achievements marked significant progress in the Council's regulatory and developmental functions:
"To safeguard public health by ensuring the provision of high quality, safe and effective pharmaceutical care through the regulation of the pharmacy profession."
The Annual Report provides comprehensive data on pharmacist registration for 2017, offering insights into the growth and composition of the pharmacy workforce in Singapore. In 2017, the total number of registered pharmacists increased by 7.2% compared to the previous year, bringing the total to 3,247 pharmacists. This growth reflects the increasing demand for pharmaceutical services across Singapore's healthcare ecosystem.
The Council noted an increase in applications from foreign-qualified pharmacists, reflecting Singapore's growing attractiveness as a destination for pharmacy professionals and the Council's efforts to maintain high standards while facilitating international mobility.
The Singapore Pharmacy Council prioritized professional development in 2017, recognizing the importance of continuous learning for maintaining high standards of pharmaceutical care. Several key initiatives were implemented during the year:
2017 marked the first full year of the mandatory CPE framework. All registered pharmacists were required to complete 50 CPE points over a two-year cycle, including points in core competency areas. The framework was designed to ensure pharmacists maintain competence across fundamental areas of practice while allowing for specialization in emerging areas.
The Council developed a framework for recognition of pharmacy specializations in 2017. This included criteria for accreditation of specialist training programs and a structured approach to recognizing pharmacists with advanced expertise in areas such as oncology, geriatrics, and critical care.
In collaboration with healthcare institutions and academic partners, the SPC launched leadership development programs for senior pharmacists, preparing them for expanded roles in Singapore's evolving healthcare system.
The revised Code of Ethics for pharmacists, implemented in 2017, emphasized:
Maintaining public confidence in the pharmacy profession requires robust enforcement mechanisms. In 2017, the Singapore Pharmacy Council strengthened its regulatory functions through several measures:
The Council received 32 complaints against pharmacists in 2017, a slight decrease from 2016. After thorough investigation, 15 cases advanced to formal disciplinary proceedings, resulting in the following outcomes:
The Council enhanced its audit program in 2017, conducting both announced and unannounced inspections of pharmacy practice sites. This included 67 community pharmacies and 23 hospital pharmacy departments. Compliance rates improved compared to previous years, with 94% of sites meeting all required standards.
Building on previous years' work, the SPC issued new guidance on clinical governance for pharmacy practice, emphasizing systems for quality improvement, risk management, and patient safety.
The Council collaborated with the Health Sciences Authority to address concerns about online sales of pharmacy-only medicines, implementing measures to protect consumers from potentially illegal online pharmacy operations.
The 2017 Annual Report outlines strategic directions for the Singapore Pharmacy Council for the coming years, aligning with broader national healthcare priorities:
The Council will work with the Ministry of Health to develop frameworks for expanded pharmacist roles, particularly in chronic disease management, vaccination services, and minor ailments schemes.
Recognizing the growing importance of digital health, the SPC plans to develop guidance for tele-pharmacy services and establish standards for digital prescribing and dispensing systems.
Building on 2017's initiatives, the Council aims to further enhance pharmacy specialty training pathways and develop a more structured approach to advanced practice recognition.
The SPC will continue to develop and implement a comprehensive quality framework for pharmacy services, incorporating outcome measures and patient experience indicators.
Strengthening ties with international pharmacy regulatory bodies remains a priority, with particular focus on mutual recognition agreements and benchmarking of standards.
The Singapore Pharmacy Council's 2017 Annual Report reflects a year of significant progress and renewed commitment to advancing pharmacy standards. Through its regulatory, developmental, and enforcement activities, the Council has strengthened the foundation for excellence in pharmaceutical services across Singapore.
As Singapore's healthcare landscape continues to evolve, the pharmacy profession will play an increasingly vital role in preventive care, chronic disease management, and patient safety. The initiatives outlined in this report position the pharmacy workforce to meet these changing needs effectively.
The Council's work in 2017 demonstrates its dedication to protecting public health while supporting the professional development of pharmacists. With plans for expanded scopes of practice, enhanced digitization, and continued quality improvement, the future of pharmacy in Singapore is both promising and patient-centered.
